Burdette JE - Search Results

1

Prolactin signaling drives tumorigenesis in human high grade serous ovarian cancer cells and in a spontaneous fallopian tube derived model.

Karthikeyan S, Russo A, Dean M, Lantvit DD, Endsley M, Burdette JE. Karthikeyan S, et al. Among authors: burdette je. Cancer Lett. 2018 Oct 1;433:221-231. doi: 10.1016/j.canlet.2018.07.003. Epub 2018 Jul 5. Cancer Lett. 2018. PMID: 29981811 Free PMC article.

2

Evaluating the progenitor cells of ovarian cancer: analysis of current animal models.

King SM, Burdette JE. King SM, et al. Among authors: burdette je. BMB Rep. 2011 Jul;44(7):435-45. doi: 10.5483/BMBRep.2011.44.7.435. BMB Rep. 2011. PMID: 21777513 Free PMC article. Review.

3

The impact of ovulation on fallopian tube epithelial cells: evaluating three hypotheses connecting ovulation and serous ovarian cancer.

King SM, Hilliard TS, Wu LY, Jaffe RC, Fazleabas AT, Burdette JE. King SM, et al. Among authors: burdette je. Endocr Relat Cancer. 2011 Sep 20;18(5):627-42. doi: 10.1530/ERC-11-0107. Print 2011 Oct. Endocr Relat Cancer. 2011. PMID: 21813729 Free PMC article.

4

Glycogen synthase kinase 3β inhibitors induce apoptosis in ovarian cancer cells and inhibit in-vivo tumor growth.

Hilliard TS, Gaisina IN, Muehlbauer AG, Gaisin AM, Gallier F, Burdette JE. Hilliard TS, et al. Among authors: burdette je. Anticancer Drugs. 2011 Nov;22(10):978-85. doi: 10.1097/CAD.0b013e32834ac8fc. Anticancer Drugs. 2011. PMID: 21878813 Free PMC article.

5

The lymphotactin receptor is expressed in epithelial ovarian carcinoma and contributes to cell migration and proliferation.

Kim M, Rooper L, Xie J, Rayahin J, Burdette JE, Kajdacsy-Balla AA, Barbolina MV. Kim M, et al. Among authors: burdette je. Mol Cancer Res. 2012 Nov;10(11):1419-29. doi: 10.1158/1541-7786.MCR-12-0361. Epub 2012 Sep 10. Mol Cancer Res. 2012. PMID: 22964431

6

Early transformative changes in normal ovarian surface epithelium induced by oxidative stress require Akt upregulation, DNA damage and epithelial-stromal interaction.

King SM, Quartuccio SM, Vanderhyden BC, Burdette JE. King SM, et al. Among authors: burdette je. Carcinogenesis. 2013 May;34(5):1125-33. doi: 10.1093/carcin/bgt003. Epub 2013 Jan 8. Carcinogenesis. 2013. PMID: 23299406

7

Conditional inactivation of p53 in mouse ovarian surface epithelium does not alter MIS driven Smad2-dominant negative epithelium-lined inclusion cysts or teratomas.

Quartuccio SM, Lantvit DD, Bosland MC, Burdette JE. Quartuccio SM, et al. Among authors: burdette je. PLoS One. 2013 May 31;8(5):e65067. doi: 10.1371/journal.pone.0065067. Print 2013. PLoS One. 2013. PMID: 23741457 Free PMC article.

8

Epithelial ovarian cancer experimental models.

Lengyel E, Burdette JE, Kenny HA, Matei D, Pilrose J, Haluska P, Nephew KP, Hales DB, Stack MS. Lengyel E, et al. Among authors: burdette je. Oncogene. 2014 Jul 10;33(28):3619-33. doi: 10.1038/onc.2013.321. Epub 2013 Aug 12. Oncogene. 2014. PMID: 23934194 Free PMC article. Review.

9

Targeting of follicle stimulating hormone peptide-conjugated dendrimers to ovarian cancer cells.

Modi DA, Sunoqrot S, Bugno J, Lantvit DD, Hong S, Burdette JE. Modi DA, et al. Among authors: burdette je. Nanoscale. 2014 Mar 7;6(5):2812-20. doi: 10.1039/c3nr05042d. Epub 2014 Jan 27. Nanoscale. 2014. PMID: 24468839

10

Prolonged blood circulation and enhanced tumor accumulation of folate-targeted dendrimer-polymer hybrid nanoparticles.

Sunoqrot S, Bugno J, Lantvit D, Burdette JE, Hong S. Sunoqrot S, et al. Among authors: burdette je. J Control Release. 2014 Oct 10;191:115-22. doi: 10.1016/j.jconrel.2014.05.006. Epub 2014 May 14. J Control Release. 2014. PMID: 24837188 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

179 results

Search Page

Filters